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Running headline: Prediction of frailty in older Japanese adults 
Abstract 
Most definitions of frailty utilize US populations in their development. The concept of 
frailty has not been well studied in Japan, which has the largest percentage of older 
patients (per capita) in the world. We created a 5-year prospective cohort study of 
community-dwelling older Japanese adults. Participants were not frail at baseline, 
based on our definition adapted from the Canadian Study for Health and Aging 
Clinical Frailty Scale. Participants underwent a comprehensive geriatric 
assessment (CGA) at baseline, and final assessments were either in person or via 
mailed survey. We enrolled 407 individuals (184 men, mean age 78 ± 4 years; 223 
women, mean age 77 ± 4 years). Sixty-five participants met criteria for frailty by the 
end of the study. In univariate analyses, eighteen separate parameters were 
associated with frailty, some of which included: age, gender, handgrip, timed walk, 
systolic blood pressure, pulse pressure, cognitive status, living alone, and hearing 
deficits. In multivariate analyses, the following elements remained associated with 
frailty: timed walk, pulse pressure, cognition deficits and hearing deficits. We 
established cut-off points for timed walk (5 meters/3 seconds) and pulse pressure 
(60 mmHg). We then created a simple additive score for these four factors 
(present=1; absent=0). A score of 0 had a 93% negative predictive value for frailty 
while a score of 4 had a 70% positive predictive value. While further study is 
needed, this work creates an easy-to-administer tool that may be generalizable to 
other populations. 
 
Keywords: frailty, prediction, gait speed, pulse pressure, cognitive deficits, hearing 
deficits  
1. Introduction 
Health maintenance and health promotion among older adults have become major 
societal issues worldwide, especially among Western nations (Cassel, 2009; 
Cruz-Jentroft et al, 2009). Furthermore, it is believed that such issues might have 
important cost and outcome benefits for society (Ackermann et al, 2008; Goetzel et 
al, 2007; Meng et al, 2009; Wieland, 2003). Although a comprehensive geriatric 
assessment (CGA) has long been used as the standard of care in the field of 
geriatrics (Li, 2010), another less formal and simpler types of assessment may be 
useful for active, relatively healthy older individuals (Jones et al, 2004,2005; Searle 
et al, 2008). In particular, proactively assessing these older adults for frailty may 
help determine which subjects need interventions to prevent poor health outcomes. 
However, a widely accepted, clinically applicable and easy-to-use definition of frailty 
has not yet been established. Fried and others (Fried et al, 2001) proposed the 
concept that frailty is a clinical phenotype characterized by several variables, 
although some of these variables (such as grip strength, timed walk) may not be 
readily clinically available. The Canadian Study for Health and Aging Clinical Frailty 
Scale (CSHA-CSF), on the other hand, uses symptoms and signs that do not 
require sophisticated clinical measurements (Rockwood et al, 2005). Controversy 
continues as to which of these models may be the most useful, and further 
research is needed to determine how the definition of frailty used relates to factors 
such as socio-economic status, comorbidities, and cognitive and sensory 
impairments (Lang et al, 2009).   
In 2000, the “New Elderly Citizen Movement” was initiated at the Life Planning 
Center Foundation in Tokyo, Japan, with the goal of encouraging older adults to 
make lifestyle changes so they could remain active and productive. Within this 
group, a research cohort was established and as of 2002, the cohort has about 
3,000 members. At baseline, these individuals were relatively healthy and active, 
although some had co-morbid illnesses that did not affect their functional status or 
ability to live independently. The details of their medical conditions and 
health-related behaviors have been reported elsewhere (Doba et al, 2011; Hinohara 
et al, 2005). The “Health Research Volunteer Study” was a cohort study within this 
program that examined the clinical phenotype and other factors associated with the 
development of frailty. This manuscript describes the factors associated with frailty 
in this study and proposes the validation of a prediction rule for frailty in this unique 
cohort of Japanese individuals. 
2. Methods 
2.1. Definition and assessment of frailty 
A consensus on the concept and diagnostic criteria for frailty has not yet been  
 
established. While Fried and others (Fried et al, 2001) have done the most work on  
 
defining the frailty phenotype, their definition was not suitable for our population.  
 
In addition to being frail, this is in part due to the fact that some older adults in our  
 
study were not available for in-person assessments (e.g. to determine walking  
 
speed or grip strength) at the end of the study because they had moved away or did  
 
not have the assistance they needed to be able to come to our clinic. 
 
 
Because of these limitations, we chose to use the CSHA-CFS definition of frailty, 
which clusters individuals along a continuum of being completely dependent and 
frail to completely healthy (Rockwood et al, 2005). The CSHA-CFS is defined as 
follows: very fit, robust, active, energetic, and highly motivated; well, without active 
disease, but less fit; well, with treated comorbid disease; apparently vulnerable, not 
dependent, but beginning to slow down; mildly frail, dependent on others for 
Instrumental Activity of Daily Living (IADLs); moderately frail, help is needed with 
IADLs; and severely frail, completely dependent or terminally ill. Both the probability 
of survival and the ability to remain independent measured by being able to avoid 
placement in a long-term care were significantly different among the seven groups 
during a 70-month follow-up period. These differences were especially obvious 
between the group with a score of 3 and the group with a score 4. Although various 
frailty models are available, and assessment of frailty remains very heterogeneous 
(Abellan van Kahn et al, 2008; Lang et al, 2009), the CSHA Clinical Frailty Scale is 
inline with the National Care Policy for Japan and could be adopted as one of the 
more widely used scales in both clinical and community practice (Chan et al, 2009). 
We used the CSHA-CFS to dichotomize subjects into two groups at the end of the 
5-year follow-up period: a non-frail group comprised of those with scores from 1 to 3 
and a frail group comprised of those with a score of 4 to 7.  
 
2.2. Subjects 
Criteria for being included in this analysis were: having contributed data for the 
5-year period ending in 2011, having a score of 1 to 3 on the CHSA-CFS at the 
baseline assessment, and having had a stable weight for the 6 months before study 
entry. From the entire cohort of 3,000 members at the Life Planning Center 407 
subjects were enrolled in the study based on the following entry criteria: age > 70 
years, well-controlled comorbid illness, sufficiently independent in IADLs, and 
having active social connections (Entry criteria adapted from Rowe et al, 1998). All 
subjects were community-dwelling and were independent in their Activities of Daily 
Living (ADLs) and IADLs at baseline. We excluded patients if they had active 
chronic infective, inflammatory, neoplastic or other moderate to severe chronic 
diseases. Patients with stable medical conditions or who were receiving 
conventional medications for those conditions (e.g. antihypertensives, lipid-lowering 
agents, or oral hypoglycemic medications) were not excluded. Study endpoints 
were death, development of frailty, drop-out, or study termination. 
 
At the end of the 5-year study period, all enrolled subjects were contacted and 
asked to come to the Life Planning Center for a final assessment. When subjects 
were unable because they were too ill or otherwise unavailable, we contacted them 
or their caregivers via telephone or mail. Subjects who could not be contacted at the 
final assessment were considered dropouts and were removed from the study. 
Written informed consent was obtained from all the participants, and ethical 
permission was obtained from the Committee of the Japan Society of Health 
Evaluation and Promotion. 
 
2-3. Determination of Frailty 
The study committee consisting of 21 members and included physicians, 
sociologists, psychologists, statisticians, dieticians, nurses and medical technicians 
who held regular meetings three times a year. Two physicians made the 
determination of frailty based on the pre-defined criteria, and these decisions were 
reported to the larger committee meeting where the final determination was 
accepted by a consensus process. When there was a lack of clarity as to whether a 
subject had a score of three or four (4 cases, 6% of subjects), the following 
additional criteria were used to make the frailty determination: exercise tolerance 
(inability to walk 800m without resting and/or to climb 10 steps with ease), fatigue, 
weight loss more than 5kg for past 1 year, fall with or without fracture and 
decreased physical strength. When one of these rare cases had two or more of 
these elements, they were classified as a score of 4. In addition, in years two and 
four, clinical updates were obtained via written surveys, telephone interviews or 
through other clinical avenues. 
 
2-4. Assessment and Measurements 
Interview materials were sent to all participants in advance, and they completed the  
 
instruments on their own. They then brought these forms in to be reviewed and  
 
confirmed by one of 4 trained study nurses in one-on-one conversations with  
 
subjects. Questions were multiple choice in nature, and response options were:  
 
none (0), slightly (1), obviously (2) [translated from Japanese]. For example, when  
 
asked about difficulties with hearing, 0 signifies no problems, 1 signifies slight  
 
problems in mildly noisy situation, and 3 signifies obvious hearing difficulty in any  
 
situation. All study procedures were carefully documented and monitored. 
 
The survey instrument consisted of four parts: 1) a section assessing daily activities 
and changes in physical and cognition function; 2) a section reviewing their current 
medical conditions and treatments; 3) depression screening and 4) a detailed 
dietary assessment. Cognitive assessment was confirmed using the Minimum Data 
Set cognitive performance scale by Morris and others (Morris et al,1994). After 
completing these assessments, all subjects underwent a physical examination 
performed by the attending physicians at the Life Planning Center Clinic in Tokyo, 
who are specialized in internal medicine and cardiology.  
 
As part of these assessments, the following parameters were obtained: height (cm), 
weight (kg), body mass index, body fat ratio (%; bio-impedance method using 
TBF-110/210 equipment from TANITA), total body fat mass (kg), total body nonfat 
mass (kg; body weight – total body fat mass), and maximum mid-arm and mid-calf 
circumferences (cm). Skin-fold measurements (mm) were performed on the dorsal 
aspect of the triceps and the muscular area of the mid-portion of the upper arm. 
Other functional measurements that were obtained included: a single measurement 
of grip strength of the dominant hand (kg with Grip D, T.K.K.5401), timed walk 
(number of seconds to walk 5 meters using a start/stop methodology), resting 
metabolic ratio (kcal/min), bone mineral density of the 2nd to 4th lumbar vertebrae 
(DEXA: g/cm2). Cardiovascular parameters assessed included: the systolic, 
diastolic, and pulse pressures (mmHg): heart rate (beats/minute); and 
brachial-ankle pulse wave velocity (cm/second). Laboratory tests included: 
complete blood count, creatinine, blood urea nitrogen, serum electrolytes (Na, K), 
total cholesterol, total protein, albumin, hemoglobin A1c, serum osmolality, cortisol, 
luteinizing hormone, free testosterone for men, dehydroepiandrosterone sulphate, 
C-reactive protein, and interleukin-6. Socio-demographic data collected included: 
whether the subject lived with a spouse (yes/no); whether the subject lived with 
other persons (yes/no); frequency of going out (frequency/week: frequent≧3 days, 
rare≦2 days); anorexia (yes/no); insomnia (yes/no); exercise tolerance (ability to 
walk 800 m without resting and ability to climb 10 steps with ease); subjective 
cognitive changes during the past 3 years (none, slight, or obvious); mood changes 
(none, slightly depressed, or depressed); fatigability (none, slight, or obvious); 
history of falls or fracture during the past 3 years (yes/no); hearing deficits (none, 
slight, or obvious); poor distance vision (none, slight, obvious) and decreased 
physical strength (none, slight, or obvious). This comprehensive geriatric 
assessment was performed at both the baseline and the study termination visits. A 
simplified version of the functional status questionnaire was sent to all the 
participants at the end of the second and fourth years to confirm their vital status 
(dead/alive), level of function, and degree of frailty. 
 
2.5 Statistical analyses 
All the data were analyzed using SPSS version 15.0J (Tokyo, Japan). Parametric 
variables were expressed as the mean ± 1 SD and were analyzed using the Student 
t-test. Non-parametric variables were analyzed using the Fisher exact test. The 
correction for the type 1 error was applied by Bonferroni’s methods. A stepwise 
multiple logistic regression analysis was used to identify factors independently 
associated with the outcome of frailty. For significant parametric factors identified 
using the multiple logistic regression analysis, ROC curves were constructed to 
determine a cut-off point with an acceptable sensitivity and specificity. Furthermore, 
using the factors identified as significant in the multiple logistic regression analysis, 
a predictive model for frailty syndrome was developed and its negative and positive 
predictive values were determined. A two-tailed P value less than 0.05 was 
considered significant. 
3. Results 
3.1 Description of the Study Population 
The mean age of the 407 subjects at baseline was 78 ± 4 years, with no difference 
between men and women (184 men, mean age of 78 ± 4 years; 223 women, mean 
age of 77 ± 4 years; p=0.349). During the 5-year follow-up period, 22 patients died 
(Table 1); there were no significant differences in terms of gender or age of 
deceased patients. The major cause of death was cancer (n=8, 36%) followed by 
cardiovascular and/or cerebro-vascular accidents (n=5, 23%). Overall, the dropout 
rate was 8.4% (Table 1); there were no significant differences in age or gender 
between those who stayed in the study and those who dropped out. There were no 
other statistically significant differences between those who dropped out in terms of 
the measured non-parametric and parametric variables.  
 
3.2 Incidence of frailty 
As per the inclusion criteria, none of the subjects who entered the HRVS were frail 
at baseline. After the 5-year follow-up period, 65 subjects were frail according to the 
CSHA-CFS (Table 1). Of these, 35 subjects had a frailty score of 4, 25 had a score 
of 5, 2 subjects were classified as level 6, and 3 subjects had a score of 7.  
 
3.3 Prediction of frailty 
Univariate analyses of the differences between non-frail and frail subjects revealed 
a slight but statistically significant difference in subjects’ age (78 ± 4 years for men 
and 77 ± 4 years for women at baseline; p=0.049; see Table 2) and gender, with 19 
men and 46 women meeting the criteria for frailty (p=0.006; see Table 3). Univariate 
analyses also revealed significant differences between the non-frail and frail groups 
for the following parametric variables: height, weight, upper arm muscle area, calf 
circumference, bone mineral density (BMD), hand-grip of dominant side, slow timed 
walk, systolic pressure, pulse pressure, hemoglobin, luteinizing hormone and 
dehydroepiandrosterone sulphate (see Table 2). Significant differences for the 
following non-parametric variables were also observed: gender, cognitive changes, 
hearing deficits, history of a fall, living with a spouse, and urinary incontinence (see 
Table 3).  
In the multivariate analysis, the following five variables were significantly associated 
with frailty: pulse pressure, cognitive changes, slow timed walk, calf circumference, 
and hearing deficits. The ROC curves for the three parametric variables revealed 
the following cut-off points: 3.0 seconds/ 5 meters for timed walk, 60 mmHg for 
pulse pressure, and 35 cm for calf circumference. A logistic model was assembled 
using these five variables, and the following four variables were found to be 
statistically significant for the prediction of frailty: pulse pressure (>= 60 mmHg), 
subjective cognitive changes (present), slow timed walk (> 3 seconds/5 meters) and 
presence of hearing deficits (see Table 4).  
Since the magnitudes of the odds ratios for the four explanatory variables were 
similar (see Table 4), a predictive scoring model was developed that consisted of 
simply adding the presence of elements together (present, 1; absent, 0) (see Table 
5). In this scoring system, a pulse pressure >= 60 mmHg was given 1 point; 
presence of cognitive changes was given 1 point; slow timed walk was given1 point 
if it took more than 3 seconds to walk 5 meters; and hearing deficits were scored 1 
point if present. This model for frailty showed a 93% negative predictive value for a 
score of 0 (n=55, non-frailty= 51) and a 70% positive predictive value for a score of 
4 (n=10, frailty=7). The ROC area of this model was 0.734 (95%CI, 0.661 – 0.806).  
4. Discussion 
This is the first longitudinal cohort study of community-dwelling older adults 
examining the incidence of frailty in Japan. We found the incidence of frailty in this 
population to be approximately 16.0% during the 5 year follow-up period; slow 
timed walk, pulse pressure, cognitive status, and hearing deficits were significant 
predictors of the frailty syndrome. We also created and validated a simple 
prediction scale for frailty.  
 
4.1 Biological significance of variables associated with frailty 
In our study, the incidence of frailty was 2.3 times higher among women than 
among men, and this is in line with what previous studies have reported. This 
gender difference has traditionally been explained as being related to sarcopenia as 
well as neuroendocrine and/or immune deficiencies (Abdel-Rahman et al, 2009; 
Byalow et al, 2007; Maggio et al, 2010; Sharifi et al, 2005, Walstone et al, 1999). 
For example, muscle mass has been assumed to be larger among men than among 
women; therefore, a longer time is required for the development of sarcopenia in 
men than in women. Another element is that growth hormones and androgens also 
affect muscle mass, thus making it more likely that women would lose muscle mass. 
Finally cortisol dysregulation, which is seen more frequently in women than in men, 
may also play a role in the development of frailty by gender.  
 
Decreased movement at baseline is another characteristic finding in frail elderly 
individuals, and this characteristic can be evaluated using the timed walk or other 
assessments of gait speed (Working Group on Functional Outcome Measure for 
Clinical Trials, 2008, Abellum van Kan et al, 2009). Our finding that having a slow 
timed walk was one of the most significant predictors of frailty. This is consistent 
with that reported in the literature, and may be related to both morphological and 
functional declines in the musculo-skeletal system (Drey et al, 2011; Theou et al, 
2008) as well as cognitive deficits (Abellan van Kan,2011; Ijmker, 2011).  
 
The relation between frailty and cardiovascular disease is well established,  
 
although most studies focus on ischemic heart disease and heart failure (Afilalo et  
 
al, 2009; Cacciatoreetal,20005). Only a few studies have examined the relationship  
 
between hypertension and frailty (DiBriet al, 2004; Gray et al, 2009). In our study,  
 
the multivariate analysis using both forward and backward stepwise regression  
 
revealed the pulse pressure to be a significant predictor of frailty. For the past  
 
several years, discussions have focused on the utility of antihypertensive treatment  
 
for patients over the age of 80 years, and several studies have supported this  
 
treatment (Forette et al, 2002; Mancia et al, 2008; O’Rourk, 2005; Yano et al, 2011).  
 
However, adequate blood pressure levels for the treatment of very elderly 
hypertensive populations have not been described. The Japanese Society of 
Hypertension Committee has recommended 140/90 mmHg as being the upper 
acceptable limits for hypertension in older adults, but this recommendation has not 
been backed with evidence from studies of adults in Japan (Ogihara etal, 2009). 
Thus our study may add further evidence for close monitoring of blood pressure in 
older Japanese adults. although further study about the relationship of controlling 
hypertension and the development of frailty is needed.  
 
Our model includes sensory impairment as a potential predictor of frailty. This is an 
important distinction, as other models focus almost exclusively on physiologic 
parameters but not common geriatric syndromes. Thus our model provides 
potential insight into the role of geriatric syndromes in the development of frailty, 
which is currently relevant given the increasing worldwide health initiatives that 
have begun to focus on older adults who require assistance with their ADLs (Lang, 
2009) The findings from our pilot study concur with those previously published by 
Rockwood and colleagues (Searle, 2008). In addition, our relationship of sensory 
impairment to frailty is consistent with that of others in the literature (Cigolle, 2007; 
Gurina, 2011;Lang, 2009). However, in our study, pure tone audiometry with both 
2,000Hz and 4,000Hz did not reveal significant differences between frail and 
non-frail subjects. We hypothesize that peripheral auditory receptive mechanisms 
are intact and the difficulty in hearing may be related to other central nervous 
system factors or cognitive function in these older adults (Gates, 2008; Idrizbegovic, 
2011 ). 
      
4.2 Study limitations  
This study was a single-center prospective observational cohort study, and the  
 
inclusion criteria clearly defined the participants as being healthy and independent  
 
at baseline. In addition, all the participants in the study were members of the New  
 
Elderly Citizens Movement, the primary purpose of which is to encourage older  
 
adults to lead not only physically, but also socially, and spiritually active lives. As a  
 
result, there may have been a selection bias to include participants who were  
 
interested in not becoming frail. While we had specific reasons for choosing the  
 
CSHA-CFS based on both Japanese culture as well as our population in particular,  
 
some have questioned its use. Another limitation is that we could not obtain some  
 
data on a portion of the frail population at the end of the study because they were  
 
unable to visit the Life Planning Center Clinic for a final assessment. Additionally, of  
 
the subjects who were not able to visit the center at the end of the study, 45 were  
 
judged as frail, and this represents a relatively large portion of the total population of  
 
frail subject. While this is a limitation, its impact is lessened somewhat by the fact  
 
that it was easy to discern the frailty status of these individuals; that is, there was no  
 
difficulty in scoring these 45 subjects who are not interviewed in person. Also,  
 
since our model would be that our sample size of frailty was small (65 subjects), it is  
 
clear that further study is needed to validate our frailty index in other large scale  
 
populations of older adults. Even though our population was from a single center,  
 
the evaluation of the frailty phenotype in this group of Japanese older adults helps  
 
to explore differences in the ways the CHSA scale diagnoses frailty in  
 
non-Caucasian populations. Our future work will need to further elucidate the  
 
inter-relationship of these factors as well through another 5 year follow-up study to  
 
the same cohort, and also some trials for preventative approach to subjects defined  
 
at risk could be designed. 
 
4.3 Conclusion 
The concept of frailty undoubtedly plays an important role in terms of health 
promotion and maintenance, but also in terms of improving caregiver burden and 
decreasing costs. This importance will only become increasingly apparent in the 
future given the nature of rapidly aging societies across the world. Although 
numerous studies have examined models of frailty and reported on its natural 
outcomes, studies on its incidence have been reported less often. This is especially 
true for populations outside the United States. While further work is needed to 
validate our finding, these results describe a specific phenotype that may be easily 
applied to predict frailty and thus improve health outcomes for older adults. 
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Table 1. Final disposition of study subjects 
 
     Male    Female    Total ％ 
Dropout   １３   ２１   ３４   ８．４ 
Death   １４    ８       ２２    ５．４ 
Frail/phone or mail   １１   ３４      ４５ (１１．0) 
Frail/CGA ８ １２ ２０ (４．９) 
Frailty total １９ ４６ ６５            １６．０ 
Non-frail/phone or mail １１ １ １２ （２．９） 
Non-frailty/CGA   １２７  １４７ ２７４ (６７．３) 
Non-frailty/total １３８ １４８ ２８６ ７０．２ 
Total   １８４   ２２３ ４０７ １００．０ 
CGA: Comprehensive Geriatric Assessment 
Table 2. Baseline Characteristics of frail versus non-frail participants (parametric 
variables) 
 
Parametric variables Non-frail(n=286) Frail(n=65) p value 
Age (years) 77±4 78±4  0.049 
Height (cm)      156±8    153±8 0.032 
Weight (kg)       55±9       52±9  0.017 
Body Mass Index       23±3       22±3  0.256 
Upper Arm Skin Fold (mm)       15±7       16±3  0.617 
Upper Arm Muscle Area (cm2)       38±9       35±7  0.015 
Upper Arm Circumference(cm)       26±3       26±3  0.098 
Calf Circumference(cm)       35±3       34±3  0.007 
Bone Mineral Density(g/cm2)     0.90±0.21     0.82±0.20  0.002 
Hand Grip dominant side(kg)       26±7       22±7 0.001* 
Timed walk(sec/5 meters)      2.7±0.5      3.1±0.8  0.000* 
Resting Metabolic Rate (kcal/min) 1.058±0.294 0.987±0.225 0.072 
Audiometry right 2,000Hz(dB) 29±18 25±18 0.169 
Audiometry right 4,000Hz(dB)      43±21 41±20 0.580 
Audiometry left 2,000Hz(dB) 29±18 28±18 0.727 
Audiometry left 4,000Hz(dB) 42±21 42±21 0.976 
Systolic Pressure (mmHg)     135±17     140±21  0.046 
Diastolic Pressure (mmHg)      78±10      77±11  0.796 
Pulse Pressure (mmHg)      57±12      64±18  0.000* 
Ankle Brachial Index    1.15±0.09     1.13±0.10  0.128 
Pulse Wave Velocity (cm/sec)   1845±353    1933±414  0.080 
Heart Rate (bpm)      69±11      70±12  0.680 
Hemoglobin (g/ml)    13.6±1.3     13.1±1.2  0.002 
Total Cholesterol (mg/dl)     217±32     214±34  0.485 
Serum Creatinine (mg/dl)    0.81±0.22     0.76±0.21  0.099 
Serum Total Protein (g/dl)     7.2±0.4      7.2±0.4  0.576 
Serum Albumin (g/dl)     4.2±0.2      4.2±0.2  0.498 
Serum Cortisol (micg/dl)    10.9±9.5     11.6±3.8  0.188 
Luteinizing Hormone (ng/ml)      14±9      19±11  0.002 
Dehydroepiandrosterone (ng/ml)    756±435     587±316  0.003 
C-Reactive Protein (mg/dl) 1.11±0.43 0.09±0.10  0.450 
Interleukin-6(pg/ml)    2.01±2.95    2.33±1.98  0.410 
Lymphocyte count (n/μl)   1179±544    1711±554  0.363 
*Significant by Bonferroni’s correction for type I error (p<0.05/33=0.0015 
Table 3. Baseline characteristics of frail versus non-frail participants (non-parametric 
variables, determined using the Fisher exact test) 
 
Nonparametric variables Non-frail (N=286) Frail (n=65) Two-tailed P value 
Sex (female/male) 148/138 46/19 0.006 
Hypertension (a/p) 207/79 46/19 0.878 
Hypercholesterolemia（a/p） 246/39 54/10 0.692 
Diabetes mellitus (a/p) 258/27 57/7 0.649 
Smoking (a/p) 263/23 61/4 0.798 
Living with spouse (y/n) 130/156 19/46 0.018 
Living with others (y/n) 103/183 27/38 0.477 
Frequent going out (f/r) 145/118 27/32 0.198 
Appetite loss (a/p) 276/10 65/0 0.218 
Cognitive change (a/p) 159/127 22/43      0.002* 
Fall (a/p) 233/53 44/21 0.018 
Fracture (a/p) 256/30 52/13 0.056 
Hearing deficit (a/p) 212/74 34/31 0.001* 
Pain (a/p) 235/51 46/19 0.057 
Insomnia (a/p) 216/70 51/14 0.748 
Urinary incontinence (a/p) 256/31 51/14 0.037 
* Significant by Bonferroni’s correction for type I error (p<0.05/15=0.0033) 
Abbreviations: a(absent), p(present), y(yes), n(no), f(frequent), r(rare). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. List of parameters near or reaching significance according to multivariate 
logistic regression analysis 
 
Variables Walt value Two-tail P value Odds ratio 
95% confidence interval 
of odds ratio 
Calf circumference 3.374 0.066 1.794 0.962～3.347 
Timed walk 14.665 0.000 3.282 1.786～6.030 
Pulse pressure 5.767 0.016 2.074 1.144～3.761 
Cognitive change 9.389 0.002 2.641 1.419～4.915 
Hearing deficit 6.471 0.011 2.186 1.197～3.995 
 
Table 5．Prediction scoring model for frailty 
 
Variables Score 
Timed walk>=3 secconds/5 meters 1 
Pulse pressure>=60 mmHg 1 
Cognitive change (yes) 1 
Hearing deficit(yes) 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Highlights 
 
 Taking more than 3 seconds to walk 5 meters was a significant predictor of frailty. 
 Others predictors were a wide pulse pressure, cognition and hearing deficits. 
 We constructed a simple additive score for predicting frailty.  
 A score of 0 had a 93% negative predictive values for frailty. 
 A score of 4 had a 70% positive predictive value for frailty. 
 
